drugset / Trial / NCT01971385
Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
RandomizedParallel-groupDouble-blindTreatment
Summary
Subjects with a history of recurrent herpes labialis will be sensitized with either 2% SADBE or placebo. Following this, subjects sensitized with 2% SADBE will received.2% sqauric acid or.5% squaric acid on their cold sore within 72 hours of a recurrence. Subjects sensitized with placebo solution will receive placebo solution on their cold sore within 72 hours of a recurrence. Subjects will be followed for up to 6 mos after application of study medication.
Timeline
- Start
- 2013-10
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Squaric Acid Dibutyl Ester | Small molecule | 0.2 % | — |
| Comparator | Squaric Acid Dibutyl Ester | Small molecule | 0.5 % | — |